Takeda Pharmaceutical (TAK) Shareholder's Equity (2017 - 2026)
Takeda Pharmaceutical (TAK) Shareholder's Equity (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Takeda Pharmaceutical | 169,609.19 | -6.60 Bn | 4.39 Bn | 49.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.58 Bn |
| Dec 31, 2025 | 49.67 Bn |
| Sep 30, 2025 | 48.40 Bn |
| Jun 30, 2025 | 47.45 Bn |
| Mar 31, 2025 | 45.46 Bn |
| Dec 31, 2024 | 48.80 Bn |
| Jun 30, 2024 | 50.10 Bn |
| Mar 31, 2024 | 49.08 Bn |
| Dec 31, 2023 | 45.62 Bn |
| Sep 30, 2023 | 48.96 Bn |
| Jun 30, 2023 | 50.51 Bn |
| Mar 31, 2023 | 48.04 Bn |
| Dec 31, 2022 | 43.72 Bn |
| Sep 30, 2022 | 48.61 Bn |
| Jun 30, 2022 | 48.85 Bn |
| Mar 31, 2022 | 48.92 Bn |
| Dec 31, 2021 | 46.91 Bn |
| Sep 30, 2021 | 48.37 Bn |
| Jun 30, 2021 | 48.42 Bn |
| Mar 31, 2021 | 48.91 Bn |